Longterm Hodgkins survivor encourages others impacted by radiation late effects. After TAVR for aortic stenosis, Susan Strong is an AHA Heart Valve Ambassador.
OPDIVO® (nivolumab), for the treatment of patients with classical Hodgkin Lymphoma (cHL) that has relapsed or progressed after autologous HSCT and brentuximab vedotin or after...